AIM
BIIB icon

AXA Investment Managers’s Biogen BIIB Stock Holding History

AXA Investment Managers’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$16.6M Buy
+118,311
New +$16M 0.04% 318

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

AXA Investment Managers's BIIB Position: Q3 2025 in Review

AXA Investment Managers opened a new position in Biogen (BIIB) in Q3 2025: 118,311 shares worth $16.6M. The stake represents 0.04% of the portfolio and ranks #318 among its holdings.

905 funds tracked by Wall St. Rank hold BIIB as of Q3 2025.

  • AXA Investment Managers held 118,311 shares of Biogen worth $16.6M as of Q3 2025.
  • Biogen was a new AXA Investment Managers position in Q3 2025.
  • Biogen made up 0.04% of AXA Investment Managers's portfolio in Q3 2025, its #318 holding.
  • 905 funds tracked by Wall St. Rank held Biogen as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.